Treatment

NBI-1117570 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
This study is testing a new medicine, NBI-1117570, for adults aged 18-55 who are in hospital because of a flare-up of their schizophrenia symptoms. It aims to see if the new medicine helps improve these symptoms compared to a dummy pill.
For: Schizophrenia
Bulgaria · United Kingdom